L-DOPA uptake in astrocytic endfeet enwrapping blood vessels in rat brain

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Inyushin, M Y ^a   Huertas, A ^a   Kucheryavykh, Y V ^a   Kucheryavykh, L Y ^a   Tsydzik, V ^a   Sanabria, P ^a   Eaton, M J ^a   Skatchkov, S N ^a   Rojas, L V ^a   Wessinger, W D ^b  

^a UNIVERSIDAD CENTRAL DEL CARIBE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (DIMETHYLAMINO)STYRYL] N METHYLPYRIDINIUM; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; LEVODOPA; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN SLICE; CONFOCAL MICROSCOPY; DRUG METABOLISM; DRUG UPTAKE; FEMALE; FLUORESCENCE ANALYSIS; HISTOCHEMISTRY; MALE; NONHUMAN; PATCH CLAMP; PERICYTE; PRIORITY JOURNAL; RAT;

EID: 84864962248     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/321406     Document Type: Article

References (47)

1. Simard M., Arcuino G., Takano T., Liu Q. S., Nedergaard M., Signaling at the gliovascular interface The Journal of Neuroscience 2003 23 27 9254 9262 (Pubitemid 37243827)
2. Heimark R. L., Pardridge W. M., Cell-cell adhesion of molecules the blood-brain barrier The Blood-brain Barrier: Cellular and Molecular Biology 1993 New York, NY, USA Lippincott-Raven 88 106
3. Brightman M. W., Reese T. S., Junctions between intimately apposed cell membranes in the vertebrate brain Journal of Cell Biology 1969 40 3 648 677
4. Morgello S., Uson R. R., Schwartz E. J., Haber R. S., The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes GLIA 1995 14 1 43 54
5. Kageyama T., Nakamura M., Matsuo A., Yamasaki Y., Takakura Y., Hashida M., Kanai Y., Naito M., Tsuruo T., Minato N., Shimohama S., The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier Brain Research 2000 879 1-2 115 121
6. Matsuo H., Tsukada S., Nakata T., Chairoungdua A., Kim D. K., Cha S. H., Inatomi J., Yorifuji H., Fukuda J., Endou H., Kanai Y., Expression of a system L neutral amino acid transporter at the blood-brain barrier Neuroreport 2000 11 16 3507 3511
7. Uchino H., Kanai Y., Kim D. K., Wempe M. F., Chairoungdua A., Morimoto E., Anders M. W., Endou H., Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition Molecular Pharmacology 2002 61 4 729 737 (Pubitemid 34273151)
8. Ohtsuki S., Yamaguchi H., Kang Y. S., Hori S., Terasaki T., Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson's disease Biological and Pharmaceutical Bulletin 2010 33 7 1250 1252
9. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., Endou H., Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) Molecular Pharmacology 2002 61 4 729 737
10. Tsai M. J., Lee E. N. Y., Characterization of L-DOPA transport in cultured rat and mouse astrocytes Journal of Neuroscience Research 1996 43 490 495
11. Kim D. K., Kim I. J., Hwang S., Kook J. H., Lee M. C., Shin B. A., Bae C. S., Yoon J. H., Ahn S. G., Kim S. A., Kanai Y., Endou H., Kim J. K., System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells Neuroscience Research 2004 50 4 437 446 (Pubitemid 39572990)
12. Inazu M., Takeda H., Matsumiya T., Functional expression of the norepinephrine transporter in cultured rat astrocytes Journal of Neurochemistry 2003 84 1 136 144 (Pubitemid 36182074)
13. Inazu M., Takeda H., Matsumiya T., Molecular and functional characterization of an Na + -independent choline transporter in rat astrocytes Journal of Neurochemistry 2005 94 5 1427 1437 (Pubitemid 41232598)
14. Pinto-do- P. C., Soares-da-Silva P., Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules British Journal of Pharmacology 1996 118 3 741 747
15. Becker M., Visser L., van Schaik R., Hofman A., Uitterlinden A., Stricker B., OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users Neurogenetics 2011 12 1 79 82
16. Bertler A., Falck B., Owman C., Rosengrenn E., The localization of monoaminergic blood-brain barrier mechanisms Pharmacological Reviews 1966 18 1, part 1 369 385
17. Wade L. A., Katzman R., Rat brain regional uptake and decarboxylation of l DOPA following carotid injection American Journal of Physiology 1975 228 2 352 359
18. Hardebo J. E., Falck B., Owman C., A comparative study on the uptake and subsequent decarboxylation of monoamine precursors in cerebral microvessels Acta Physiologica Scandinavica 1979 107 2 161 167 (Pubitemid 10195417)
19. De la Torre J. C., An improved approach to histofluorescence using the SPG method for tissue monoamines Journal of Neuroscience Methods 1980 3 1 1 5 (Pubitemid 11196394)
20. Ryder T. A., MacKenzie M. L., Pryse-Davies J., Glover V., Lewinsohn R., Sandler M., A coupled peroxidatic oxidation technique for the histochemical localization of monoamine oxidase A and B and benzylamine oxidase Histochemistry 1979 62 1 93 100 (Pubitemid 9234214)
21. Willoughby J., Glover V., Sandler M., Histochemical localisation of monoamine oxidase A and B in rat brain Journal of Neural Transmission 1988 74 1 29 42
22. Zhou M., Kimelberg H. K., Freshly isolated astrocytes from rat hippocampus show two distinct current patterns and different [K + ] o uptake capabilities Journal of Neurophysiology 2000 84 6 2746 2757
23. Schwartz J. W., Blakely R. D., DeFelice L. J., Binding and transport in norepinephrine transporters: real-time, spatially resolved analysis in single cells using a fluorescent substrate The Journal of Biological Chemistry 2003 278 11 9768 9777 (Pubitemid 36800476)
24. Mehrens T., Lelleck S., etinkaya I., Knollmann M., Hohage H., Gorboulev V., Boknk P., Koepsell H., Schlatter E., The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation Journal of the American Society of Nephrology 2000 11 7 1216 1224 (Pubitemid 30416217)
25. etinkaya I., Ciarimboli G., Yalinkaya G., Mehrens T., Velic A., Hirsch J. R., Gorboulev V., Koepsell H., Schlatter E., Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases American Journal of Physiology 2003 284 2 F293 F302
26. Schmitt B. M., Koepsell H., Alkali cation binding and permeation in the rat organic cation transporter rOCT2 The Journal of Biological Chemistry 2005 280 26 24481 24490 (Pubitemid 40934533)
27. Levitt P., Pintar J. E., Breakefield X. O., Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons Proceedings of the National Academy of Sciences of the United States of America 1982 79 20 6385 6389 (Pubitemid 13214252)
28. Saura J., Kettler R., Da Prada M., Richards J. G., Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain The Journal of Neuroscience 1992 12 5 1977 1999
29. Siddiqui A., Mallajosyula J. K., Rane A., Andersen J. K., Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression Neurobiology of Disease 2010 40 2 444 448
30. Privat A., Gimenez-Ribotta M., Ridet J.-C., Ransom B. R., Kettenmann H., Morphology of astrocytes Neuroglia 1995 New York, NY, USA Oxford University Press 3 22
31. Juorio A. V., Li X. M., Walz W., Paterson I. A., Decarboxylation of L-Dopa by cultured mouse astrocytes Brain Research 1993 626 1-2 306 309 (Pubitemid 23306841)
32. Li X. M., Juorio A. V., Paterson I. A., Walz W., Zhu M. Y., Boulton A. A., Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells Journal of Neurochemistry 1992 59 3 1172 1175
33. Bjrklund T., Hall H., Breysse N., Soneson C., Carlsson T., Mandel R. J., Carta M., Kirik D., Optimization of continuous in vivo DOPA production and studies on ectopic da synthesis using rAAV5 vectors in Parkinsonian rats Journal of Neurochemistry 2009 111 2 355 367
34. Ransom B. R., Kunis D. M., Irwin I., Langston J. W., Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP + Neuroscience Letters 1987 75 3 323 328 (Pubitemid 17042867)
35. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proceedings of the National Academy of Sciences of the United States of America 1985 82 7 2173 2177 (Pubitemid 15056491)
36. Cui M., Aras R., Christian W. V., Rappold P. M., Hatwar M., Panza J., Jackson-Lewis V., Javitch J. A., Ballatori N., Przedborski S., Tieu K., The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway Proceedings of the National Academy of Sciences of the United States of America 2009 106 19 8043 8048
37. Magrassi L., Purves D., Lichtman J. W., Fluorescent probes that stain living nerve terminals The Journal of Neuroscience 1987 7 4 1207 1214 (Pubitemid 17055363)
38. Papp M. I., Kahn J. E., Lantos P. L., Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) Journal of the Neurological Sciences 1989 94 13 79 100 (Pubitemid 20019446)
39. Gilman S., Low P. A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C. J., Kaufmann H., Klockgether T., Lang A. E., Lantos P. L., Litvan I., Mathias C. J., Oliver E., Robertson D., Schatz I., Wenning G. K., Consensus statement on the diagnosis of multiple system atrophy Journal of the Neurological Sciences 1999 163 1 94 98 (Pubitemid 29155424)
40. Mller T., Motor complications, levodopa metabolism and progression of Parkinson's disease Expert Opinion on Drug Metabolism and Toxicology 2011 7 7 847 855
41. Riederer P., Konradi C., Schay V., Kienzl E., Birkmayer G., Danielczyk W., Sofic E., Youdim M. B., Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl Advances in Neurology 1987 45 111 118
42. Yu P. H., Hertz L., Differential expression of type A and type B monoamine oxidase of mouse astrocytes in primary cultures Journal of Neurochemistry 1982 39 5 1492 1495 (Pubitemid 13220411)
43. Youdim M. B., Edmondson D., Tipton K. F., The therapeutic potential of monoamine oxidase inhibitors Nature Reviews Neuroscience 2006 7 4 295 309
44. Ohlin K. E., Francardo V., Lindgren H. S., Sillivan S. E., Oullivan S. S., Luksik A. S., Vassoler F. M., Lees A. J., Konradi C., Cenci M. A., Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia Brain 2011 134, part 8 2339 2357
45. Westin J. E., Lindgren H. S., Gardi J., Nyengaard J. R., Brundin P., Mohapel P., Cenci M. A., Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl- L-alanine-induced dyskinesia The Journal of Neuroscience 2006 26 37 9448 9461 (Pubitemid 44396858)
46. Astradsson A., Jenkins B. G., Choi J. K., Hallett P. J., Levesque M. A., McDowell J. S., Brownell A. L., Spealman R. D., Isacson O., The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates-evidence from in vivo neuroimaging studies Neurobiology of Disease 2009 35 3 348 351
47. Mller T., Kolf K., Ander L., Woitalla D., Muhlack S., Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease Clinical Neuropharmacology 2008 31 3 134 140 (Pubitemid 351787109)